Cargando…
Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease
We have previously demonstrated calcimimetics optimize the balance between osteoclastic bone resorption and osteoblastic mineralization through upregulating Wingless and int-1 (Wnt) signaling pathways in the mouse and cell model. Nonetheless, definitive human data are unavailable concerning therapeu...
Autores principales: | Hung, Kuo-Chin, Chang, Jia-Feng, Hsu, Yung-Ho, Hsieh, Chih-Yu, Wu, Mai-Szu, Wu, Mei-Yi, Chiu, I-Jen, Syu, Ren-Si, Wang, Ting-Ming, Wu, Chang-Chin, Hung, Lie-Yee, Zheng, Cai-Mei, Lu, Kuo-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698938/ https://www.ncbi.nlm.nih.gov/pubmed/33218086 http://dx.doi.org/10.3390/ijms21228712 |
Ejemplares similares
-
Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
por: Hou, Yi-Chou, et al.
Publicado: (2022) -
Circulating p-Cresyl Sulfate, Non-Hepatic Alkaline Phosphatase and Risk of Bone Fracture Events in Chronic Kidney Disease-Mineral Bone Disease
por: Chang, Jia-Feng, et al.
Publicado: (2021) -
Effect of zinc substitution in hydroxyapatite coating on osteoblast and osteoclast differentiation under osteoblast/osteoclast co-culture
por: Meng, Guolong, et al.
Publicado: (2019) -
Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
por: Yu, Su-Bin, et al.
Publicado: (2018) -
Ibudilast Mitigates Delayed Bone Healing Caused by Lipopolysaccharide by Altering Osteoblast and Osteoclast Activity
por: Chang, Yuhan, et al.
Publicado: (2021)